Haemonetics (HAE) News Today $67.92 +1.86 (+2.82%) Closing price 03:59 PM EasternExtended Trading$68.04 +0.12 (+0.18%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HAE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Millennium Management LLC Decreases Position in Haemonetics Co. (NYSE:HAE)Millennium Management LLC cut its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 33.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 162,307 shares of the medical instruments sMay 26 at 3:50 AM | marketbeat.comProShare Advisors LLC Increases Stock Position in Haemonetics Co. (NYSE:HAE)ProShare Advisors LLC boosted its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 40.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,486 shares of the medical instruments supplier's stock afteMay 25 at 4:03 AM | marketbeat.comD. E. Shaw & Co. Inc. Trims Position in Haemonetics Co. (NYSE:HAE)D. E. Shaw & Co. Inc. cut its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 99.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,237 shares of the medical instruments supplier's stock after selling 3,281,763 shares during the period. D. EMay 25 at 3:36 AM | marketbeat.comNomura Holdings Inc. Invests $519,000 in Haemonetics Co. (NYSE:HAE)Nomura Holdings Inc. purchased a new position in Haemonetics Co. (NYSE:HAE - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 6,652 shares of the medical instruments supplier's stock, valued at approximately $519,000. A number ofMay 24 at 4:05 AM | marketbeat.comAmeriprise Financial Inc. Sells 132,854 Shares of Haemonetics Co. (NYSE:HAE)Ameriprise Financial Inc. lessened its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 56.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 102,675 shares of the medical instruments supplier's stock after selling 132,8May 24 at 3:28 AM | marketbeat.comHaemonetics (NYSE:HAE) Given "Market Outperform" Rating at JMP SecuritiesMay 23, 2025 | americanbankingnews.comBrokerages Set Haemonetics Co. (NYSE:HAE) Price Target at $97.89May 23, 2025 | americanbankingnews.comHaemonetics Co. (NYSE:HAE) Given Average Recommendation of "Moderate Buy" by AnalystsShares of Haemonetics Co. (NYSE:HAE - Get Free Report) have been assigned an average rating of "Moderate Buy" from the nine ratings firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recoMay 22, 2025 | marketbeat.comWhat 4 Analyst Ratings Have To Say About HaemoneticsMay 21, 2025 | benzinga.comLazard Asset Management LLC Sells 7,509,830 Shares of Haemonetics Co. (NYSE:HAE)Lazard Asset Management LLC trimmed its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 99.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,936 shares of the medical instruments supplier's stock after sellingMay 21, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Bought by Janus Henderson Group PLCJanus Henderson Group PLC lifted its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 29.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 60,436 shares of the medical instruments supplier's stock afterMay 21, 2025 | marketbeat.comBNP Paribas Financial Markets Buys 16,260 Shares of Haemonetics Co. (NYSE:HAE)BNP Paribas Financial Markets grew its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 95.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 33,209 shares of the medical instruments supplier's stock after buying an additiMay 19, 2025 | marketbeat.comSilvercrest Asset Management Group LLC Increases Stock Position in Haemonetics Co. (NYSE:HAE)Silvercrest Asset Management Group LLC lifted its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 31.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 643,227 shares of the medicalMay 18, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Sold by Numerai GP LLCNumerai GP LLC trimmed its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 60.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,968 shares of the medical instruments supplier's stock after selling 9,11May 18, 2025 | marketbeat.comProsight Management LP Sells 18,300 Shares of Haemonetics Co. (NYSE:HAE)Prosight Management LP cut its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 28.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 46,700 shares of the medical instruments supplier's stock after sellingMay 17, 2025 | marketbeat.comLMR Partners LLP Makes New $2.06 Million Investment in Haemonetics Co. (NYSE:HAE)LMR Partners LLP purchased a new stake in Haemonetics Co. (NYSE:HAE - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 26,365 shares of the medical instruments supplier's stock, valued at approMay 16, 2025 | marketbeat.comHaemonetics (NYSE:HAE) Downgraded to "Hold" Rating by StockNews.comStockNews.com downgraded Haemonetics from a "buy" rating to a "hold" rating in a research note on Tuesday.May 15, 2025 | marketbeat.comLondon Co. of Virginia Has $22 Million Holdings in Haemonetics Co. (NYSE:HAE)London Co. of Virginia raised its position in Haemonetics Co. (NYSE:HAE - Free Report) by 2.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 281,738 shares of the medical instruments supplier's stock afteMay 14, 2025 | marketbeat.com49,250 Shares in Haemonetics Co. (NYSE:HAE) Acquired by Balyasny Asset Management L.P.Balyasny Asset Management L.P. acquired a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 49,250 shares of the medical instruments supplier's stock, valued at approxiMay 13, 2025 | marketbeat.comFirst Trust Advisors LP Has $328,000 Position in Haemonetics Co. (NYSE:HAE)First Trust Advisors LP cut its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 83.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,198 shares of the medical instrumentMay 12, 2025 | marketbeat.comHaemonetics Corporation Just Beat EPS By 8.7%: Here's What Analysts Think Will Happen NextMay 11, 2025 | finance.yahoo.comShould You Be Adding Haemonetics (NYSE:HAE) To Your Watchlist Today?May 11, 2025 | finance.yahoo.comExpect Equity LLC Invests $1.10 Million in Haemonetics Co. (NYSE:HAE)Expect Equity LLC bought a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 14,100 shares of the medical instruments supplier's stock, valued at approximatelMay 11, 2025 | marketbeat.comHaemonetics Full Year 2025 Earnings: EPS Beats ExpectationsMay 10, 2025 | finance.yahoo.comHaemonetics Corporation (HAE) Q4 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comHaemonetics (NYSE:HAE) Releases FY 2026 Earnings GuidanceHaemonetics (NYSE:HAE) updated its FY 2026 earnings guidance. The company provided EPS guidance of 4.700-5.000 for the period, compared to the consensus estimate of 4.540.May 10, 2025 | marketbeat.comAxa S.A. Reduces Position in Haemonetics Co. (NYSE:HAE)Axa S.A. decreased its position in Haemonetics Co. (NYSE:HAE - Free Report) by 11.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,400 shares of the medical instruments supplier's stock after selling 6,730 sharesMay 10, 2025 | marketbeat.comNorthern Trust Corp Buys 93,848 Shares of Haemonetics Co. (NYSE:HAE)Northern Trust Corp raised its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 16.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 678,261 shares of the medical instruments supplier's stock after purchasing an additional 93,848 shares during the quartMay 10, 2025 | marketbeat.comEarnings call transcript: Haemonetics Q4 2025 beats EPS forecast, stock risesMay 9, 2025 | investing.com1 Healthcare Stock to Consider Right Now and 2 to Brush OffMay 9, 2025 | finance.yahoo.comHaemonetics Corp (HAE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ...May 9, 2025 | finance.yahoo.comBrevan Howard Capital Management LP Grows Stake in Haemonetics Co. (NYSE:HAE)Brevan Howard Capital Management LP raised its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 404.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,810 shares of the medicalMay 9, 2025 | marketbeat.com5,065 Shares in Haemonetics Co. (NYSE:HAE) Acquired by Bridgefront Capital LLCBridgefront Capital LLC bought a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 5,065 shares of the medical instruments supplier's stock, valued at approximately $395,000. OMay 9, 2025 | marketbeat.comHaemonetics Corporation: Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations WebsiteMay 8, 2025 | finanznachrichten.deHaemonetics (NYSE:HAE) Surprises With Q1 SalesMay 8, 2025 | finance.yahoo.comHaemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations WebsiteMay 8, 2025 | prnewswire.comHaemonetics Co. (NYSE:HAE) Shares Sold by Comerica BankComerica Bank cut its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 10.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 67,512 shares of the medical instruments supplMay 8, 2025 | marketbeat.comHaemonetics Q4 2025 Earnings PreviewMay 7, 2025 | msn.comHaemonetics (HAE) To Report Earnings Tomorrow: Here Is What To ExpectMay 7, 2025 | finance.yahoo.comAristotle Capital Boston LLC Purchases 22,011 Shares of Haemonetics Co. (NYSE:HAE)Aristotle Capital Boston LLC grew its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 6.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 380,617 shares of the medical instrumentsMay 5, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Increases Stock Position in Haemonetics Co. (NYSE:HAE)The Manufacturers Life Insurance Company boosted its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 434.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 314,067 shares of the medicMay 5, 2025 | marketbeat.comHaemonetics (NYSE:HAE) Reaches New 1-Year Low - Should You Sell?Haemonetics (NYSE:HAE) Sets New 12-Month Low - Should You Sell?May 3, 2025 | marketbeat.comPDT Partners LLC Buys Shares of 10,168 Haemonetics Co. (NYSE:HAE)PDT Partners LLC purchased a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 10,168 shares of the medical instruments supplier's stock, valued at approMay 3, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Bought by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD raised its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 7.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 354,281 shares of the medical instruments suppMay 3, 2025 | marketbeat.comHaemonetics (HAE) Expected to Announce Quarterly Earnings on ThursdayHaemonetics (NYSE:HAE) will be releasing its Q4 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-haemonetics-co-stock/)May 3, 2025 | marketbeat.com42,599 Shares in Haemonetics Co. (NYSE:HAE) Acquired by Susquehanna Fundamental Investments LLCSusquehanna Fundamental Investments LLC bought a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 42,599 shares of the medical instruments supplier's stock, valued at approMay 2, 2025 | marketbeat.comDimensional Fund Advisors LP Purchases 10,990 Shares of Haemonetics Co. (NYSE:HAE)Dimensional Fund Advisors LP grew its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 1.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 992,229 shares of the medicalMay 2, 2025 | marketbeat.comPinebridge Investments L.P. Raises Position in Haemonetics Co. (NYSE:HAE)Pinebridge Investments L.P. grew its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 42.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,483 shares of the medical instruments supplApril 30, 2025 | marketbeat.com4,720 Shares in Haemonetics Co. (NYSE:HAE) Acquired by Dark Forest Capital Management LPDark Forest Capital Management LP acquired a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 4,720 shares of the medical instruments supplier's stock, valuApril 30, 2025 | marketbeat.comVoya Investment Management LLC Has $24.75 Million Stock Holdings in Haemonetics Co. (NYSE:HAE)Voya Investment Management LLC grew its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 820.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 316,952 shares of the medical instruments supplier'sApril 29, 2025 | marketbeat.com Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address HAE Media Mentions By Week HAE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HAE News Sentiment▼1.071.02▲Average Medical News Sentiment HAE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HAE Articles This Week▼116▲HAE Articles Average Week Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Align Technology News Merit Medical Systems News ICU Medical News DENTSPLY SIRONA News QuidelOrtho News Neogen News STAAR Surgical News Cerus News OraSure Technologies News Utah Medical Products News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HAE) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HAE Stock Free HAE Stock Alerts